- Confirmed: 这个参考离子已经通过手动审计得到确认和验证。
- Reliable: 这个参考离子可能在特定的解剖组织环境中高度保守。
- Unreliable: 这个参考离子具有较高的排名价值,但缺乏可重复性。
- Unavailable: 由于排名价值低且缺乏可重复性,这个参考离子不应用于注释。
Found 11 Reference Ions Near m/z 423.0545
NovoCell ID | m/z | Mass Window | Metabolite | Ranking | Anatomy Context |
---|---|---|---|---|---|
MSI_000001102 Unavailable | 423.0545 | 423.0545 ~ 423.0545 MzDiff: none |
Cephapirin (BioDeep_00000002204) Formula: C17H17N3O6S2 (423.0559) |
-0.39 (100%) | Mus musculus [UBERON:0001224] renal pelvis |
MSI_000001195 Unavailable | 423.0487 | 423.0487 ~ 423.0487 MzDiff: none |
n-[(1e)-2-(5-bromo-1h-indol-3-yl)ethenyl]-2-(7-hydroxy-1h-indol-3-yl)-2-oxoacetamide (BioDeep_00002210188) Formula: C20H14BrN3O3 (423.0218) |
-0.47 (100%) | Mus musculus [UBERON:0001224] renal pelvis |
MSI_000001564 Unavailable | 423.0545 | 423.0545 ~ 423.0545 MzDiff: none |
Cephapirin (BioDeep_00000002204) Formula: C17H17N3O6S2 (423.0559) |
-0.39 (100%) | Mus musculus [UBERON:0001225] cortex of kidney |
MSI_000001650 Unavailable | 423.0487 | 423.0487 ~ 423.0487 MzDiff: none |
n-[(1e)-2-(5-bromo-1h-indol-3-yl)ethenyl]-2-(7-hydroxy-1h-indol-3-yl)-2-oxoacetamide (BioDeep_00002210188) Formula: C20H14BrN3O3 (423.0218) |
-0.47 (100%) | Mus musculus [UBERON:0001225] cortex of kidney |
MSI_000002034 Unavailable | 423.0545 | 423.0545 ~ 423.0545 MzDiff: none |
Cephapirin (BioDeep_00000002204) Formula: C17H17N3O6S2 (423.0559) |
-0.39 (100%) | Mus musculus [UBERON:0001293] outer medulla of kidney |
MSI_000002116 Unavailable | 423.0487 | 423.0487 ~ 423.0487 MzDiff: none |
n-[(1e)-2-(5-bromo-1h-indol-3-yl)ethenyl]-2-(7-hydroxy-1h-indol-3-yl)-2-oxoacetamide (BioDeep_00002210188) Formula: C20H14BrN3O3 (423.0218) |
-0.47 (100%) | Mus musculus [UBERON:0001293] outer medulla of kidney |
MSI_000035166 Unreliable | 423.0471 | 423.0471 ~ 423.0471 MzDiff: none |
(5r,6r)-3-[(r)-(1e)-2-[(1-hydroxyethylidene)amino]ethenesulfinyl]-7-oxo-6-[2-(sulfooxy)propan-2-yl]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid (BioDeep_00002077362) Formula: C14H18N2O9S2 (422.0454) |
1.42 (100%) | Posidonia oceanica [PO:0006203] pericycle |
MSI_000038148 Unreliable | 423.0641 | 423.0641 ~ 423.0641 MzDiff: none |
Glucoiberin (BioDeep_00000003268) Formula: C11H21NO10S3 (423.0328) |
2.23 (100%) | Posidonia oceanica [PO:0005020] vascular bundle |
MSI_000059086 Unavailable | 423.0563 | 423.0563 ~ 423.0563 MzDiff: none |
Cephapirin (BioDeep_00000002204) Formula: C17H17N3O6S2 (423.0559) |
-0.68 (100%) | Mus musculus [UBERON:0001950] neocortex |
MSI_000059474 Unreliable | 423.0563 | 423.0563 ~ 423.0563 MzDiff: none |
Cephapirin (BioDeep_00000002204) Formula: C17H17N3O6S2 (423.0559) |
1.15 (100%) | Mus musculus [UBERON:0002298] brainstem |
MSI_000060756 Unavailable | 423.0563 | 423.0563 ~ 423.0563 MzDiff: none |
Cephapirin (BioDeep_00000002204) Formula: C17H17N3O6S2 (423.0559) |
-0.47 (100%) | Mus musculus [UBERON:0002421] hippocampal formation |
Found 5 Sample Hits
Metabolite | Species | Sample | |
---|---|---|---|
Cephapirin Formula: C17H17N3O6S2 (423.0559) Adducts: [M]+ (Ppm: 2) |
Mus musculus (Kidney) |
FULL_MS_centriod_CHCA_20210819Resolution: 17μm, 638x437
AP-MALDI instrument demo test, mass spectrum scan in centroid mode. |
|
Cephapirin Formula: C17H17N3O6S2 (423.0559) Adducts: [M]+ (Ppm: 2.1) |
Homo sapiens (esophagus) |
LNTO22_1_9Resolution: 75μm, 89x74
|
|
1-O-Caffeoyl-(b-D-glucose 6-O-sulfate) Formula: C15H18O12S (422.0519) Adducts: [M+H]+ (Ppm: 11.9) |
Mus musculus (Liver) |
Salmonella_final_pos_recalResolution: 17μm, 691x430
A more complete and holistic view on host–microbe interactions is needed to understand the physiological and cellular barriers that affect the efficacy of drug treatments and allow the discovery and development of new therapeutics. Here, we developed a multimodal imaging approach combining histopathology with mass spectrometry imaging (MSI) and same section imaging mass cytometry (IMC) to study the effects of Salmonella Typhimurium infection in the liver of a mouse model using the S. Typhimurium strains SL3261 and SL1344. This approach enables correlation of tissue morphology and specific cell phenotypes with molecular images of tissue metabolism. IMC revealed a marked increase in immune cell markers and localization in immune aggregates in infected tissues. A correlative computational method (network analysis) was deployed to find metabolic features associated with infection and revealed metabolic clusters of acetyl carnitines, as well as phosphatidylcholine and phosphatidylethanolamine plasmalogen species, which could be associated with pro-inflammatory immune cell types. By developing an IMC marker for the detection of Salmonella LPS, we were further able to identify and characterize those cell types which contained S. Typhimurium.
[dataset] Nicole Strittmatter. Holistic Characterization of a Salmonella Typhimurium Infection Model Using Integrated Molecular Imaging, metabolights_dataset, V1; 2022. https://www.ebi.ac.uk/metabolights/MTBLS2671. |
|
Cephapirin Formula: C17H17N3O6S2 (423.0559) Adducts: [M]+ (Ppm: 2.1) |
Homo sapiens (esophagus) |
LNTO22_1_7Resolution: 75μm, 69x54
|
|
Cephapirin Formula: C17H17N3O6S2 (423.0559) Adducts: [M]+ (Ppm: 2.3) |
Mus musculus (brain) |
Brain01_Bregma-3-88b_centroidResolution: 17μm, 265x320
|
|